focus -WSS

focus

author：fashion 2025-08-08 05:32:57 - browse：3157

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Illumina to lay off 10% of research and development team

hotspot

WSS

Novel spinal cord stimulator treats paralysis without surgery

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

BIO to announce reorganization, senior leaders expected to depart

Medical experts exlpore how to eliminate bias in clinical algorithms

UnitedHealth wins $3.3 billion takeover of Amedisys

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

entertainment

focus

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Brazil's Jair Bolsonaro is barred from running for office until 2030

Duchenne breakthrough therapy leaves behind pioneering families

Most antidepressants don't work on kids, teens, study finds

Continuity nursing helped my family in our darkest PICU moments

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Can gargling with Listerine treat gonorrhea of the mouth?

Medicare proposal to cover medical devices draws a mixed reaction

The strange history of BMI, the body mass index

focus

Supreme Court rules employers must be more accommodating of religious observance

Black vets could get higher VA benefits if race not used in lung test

BIO to announce reorganization, senior leaders expected to depart

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

UnitedHealth wins $3.3 billion takeover of Amedisys

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

focus

hotspot

Wikipedia

entertainment